Inventor · disambiguated record
Wendell A. Lim
Also filed as: LIM WENDELL · LIM WENDELL A
26 granted patents·35 pending applications·250 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
61 records- 0198US9587020B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Mar 7, 2017·68 cites·26 claims
- 0297US9834608B2Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Dec 5, 2017·36 cites·29 claims
- 0397US9821012B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Nov 21, 2017·27 cites·27 claims
- 0497US9670281B2Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Jun 6, 2017·51 cites·24 claims
- 0596US10105391B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Oct 23, 2018·18 cites·20 claims
- 0695US10590182B2Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Mar 17, 2020·18 cites·18 claims
- 0794US10888581B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Jan 12, 2021·5 cites·29 claims
- 0892US10836808B2Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Nov 17, 2020·6 cites·25 claims
- 0992US10822387B2Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Nov 3, 2020·5 cites·21 claims
- 1092US2025136659A1Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1190US10632152B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Apr 28, 2020·3 cites·36 claims
- 1289US11136562B2Conditionally active heterodimeric polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Oct 5, 2021·5 cites·18 claims
- 1386US11401332B2Proteolytically cleavable chimeric polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Aug 2, 2022·2 cites·11 claims
- 1485US12161672B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·18 claims
- 1585US11560561B2Modular polypeptide libraries and methods of making and using sameUNIV CALIFORNIA·Filed 2016·Granted Jan 24, 2023·3 cites·11 claims
- 1681US2025243257A1Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1779US2019002923A1Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcriptionCHARPENTIER EMMANUELLE·Filed 2018·Application pending·0 cites
- 1879US2019010520A1Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcriptionCHARPENTIER EMMANUELLE·Filed 2018·Application pending·0 cites
- 1979US2019002922A1Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcriptionCHARPENTIER EMMANUELLE·Filed 2018·Application pending·0 cites
- 2079US2019002921A1Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcriptionCHARPENTIER EMMANUELLE·Filed 2018·Application pending·0 cites
- 2178US12090170B2Methods of treating glioblastomasUNIV CALIFORNIA·Filed 2019·Granted Sep 17, 2024·1 cites·13 claims
- 2277US12371466B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Jul 29, 2025·0 cites·13 claims
- 2377US2025304698A1Proteolytically cleavable chimeric polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 2477US2019062790A1Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcriptionCHARPENTIER EMMANUELLE·Filed 2018·Application pending·0 cites
- 2575US12358988B2Proteolytically cleavable chimeric polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2022·Granted Jul 15, 2025·0 cites·17 claims
- 2674US12460199B2Modular polypeptide libraries and methods of making and using sameUNIV CALIFORNIA·Filed 2022·Granted Nov 4, 2025·0 cites·10 claims
- 2774US11478510B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Oct 25, 2022·0 cites·20 claims
- 2874US2021107965A1Binding-triggered transcriptional switches and methods of use thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2973US2017051312A1Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcriptionCHARPENTIER EMMANUELLE·Filed 2016·Application pending·0 cites
- 3072US2025034229A1Methods of treating egfrviii expressing glioblastomasUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 3171US11400116B2Systems and methods for targeting cancer cellsUNIV CALIFORNIA·Filed 2017·Granted Aug 2, 2022·1 cites·3 claims
- 3271US2024325449A1Methods of treating glioblastomasUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 3365US2015368342A1Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3464US12466892B2Systems and methods for targeting cancer cellsUNIV CALIFORNIA·Filed 2019·Granted Nov 11, 2025·0 cites·3 claims
- 3563US2024344025A1Synthetic immuno-suppressive cells and methods of use thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3663US2022213452A1Conditionally active heterodimeric polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3762US7604805B2Protein logic gatesUNIV CALIFORNIA·Filed 2003·Granted Oct 20, 2009·1 cites·3 claims
- 3862US2022409666A1Systems and methods for targeting cancer cellsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3961US2025017963A1Synthetic cytokine circuits to promote infiltration and clearance of immune excluded solid tumors by engineered immune cellsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 4060US2024342281A1Use of a stromal antigen to deliver cell-based cancer therapy to a solid tumorUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 4159US12144826B2Methods of treating EGFRvIII expressing glioblastomasUNIV CALIFORNIA·Filed 2019·Granted Nov 19, 2024·0 cites·8 claims
- 4258US2024115608A1Immune receptors with synthetic co-stimulatory domainsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 4357US2024299545A1Hybrid receptors with multiple transcriptional regulatorsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 4456US2023405120A1Engineered cellular adhesion molecules and methods of use thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 4554US2022031745A1Antigen density sensing molecular circuits and methods of use thereofUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 4654US2022265854A1Synthetic immune cells and methods of use thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4753US2024327513A1Binding-triggered regulation of protein degradationUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 4852US2023078007A1In-series synthetic receptor and-gate circuits for expression of a therapeutic payload by engineered cellsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 4951US8828658B2Spatio-temporal control of protein interactions using phytochromesVOIGT CHRISTOPHER A·Filed 2009·Granted Sep 9, 2014·0 cites·20 claims
- 5051US2023330142A1Combinatorial antigen recognition in cancer t cell therapiesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wendell A. Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →